Form4insider filings, from the source

SEC Form 4 · accession 0000921895-18-002390

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 16, 2018
Accepted (ET)
Aug 20, 2018 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
9.00% Series A Cumulative Preferred StockF3Aug 20, 2018J5,057—A159,950D
Common StockF1,F2holding———1,196,842D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (Right to Buy)F4$1.50Aug 16, 2018J1,910,397AAug 16, 2018Aug 16, 2023Common Stock1,910,3971,910,397D

Explanation of responses